• News

Party Drug Ketamine (Special K) Likely To Become Anti-Depression Medicine

  • (January 09, 2015)

The drug Ketamine, known in the party scene as "Special K," could have a future in depression treatment. Pharmaceutical companies are racing to create a patentable version of the drug and researchers are trying to learn more about the effects it has on the brain. Ketamine works by blocking the signalling molecule NMDA, which is a component of the glutamate pathway. This pathway is involved with memory and cognition, psychiatrist James Murrough at the Mount Sinai Hospital in New York City, explained to Nature magazine.

- Dr. James Murrough, Assistant Professor, Psychiatry, Neuroscience, Icahn School of Medicine at Mount Sinai

Learn more

Related Articles
Bhardwaj
Test tubes
Altered Cell State
Largest Genetic Study of Schizophrenia and African Ancestry Reveals Shared Biology Across Global Populations
Doctor adjusting microscope
An Abnormally Slow Heart Rate Is Associated With Xylazine-Fentanyl Overdose; Primarily Seen in Northeastern United States
REsearcher using computer
REsearcher using computer
New York skyscraper seen from a park
Image of researcher
REsearcher using computer